These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1151 related articles for article (PubMed ID: 30120962)

  • 61. Brainstem tau pathology in Alzheimer's disease is characterized by increase of three repeat tau and independent of amyloid β.
    Uematsu M; Nakamura A; Ebashi M; Hirokawa K; Takahashi R; Uchihara T
    Acta Neuropathol Commun; 2018 Jan; 6(1):1. PubMed ID: 29298724
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].
    Kuzuhara S
    Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Emerging Proof of Protein Misfolding and Interactions in Multifactorial Alzheimer's Disease.
    Uddin MS; Al Mamun A; Rahman MA; Behl T; Perveen A; Hafeez A; Bin-Jumah MN; Abdel-Daim MM; Ashraf GM
    Curr Top Med Chem; 2020; 20(26):2380-2390. PubMed ID: 32479244
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease.
    Jazvinšćak Jembrek M; Slade N; Hof PR; Šimić G
    Prog Neurobiol; 2018 Sep; 168():104-127. PubMed ID: 29733887
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The central role of tau in Alzheimer's disease: From neurofibrillary tangle maturation to the induction of cell death.
    Thal DR; Tomé SO
    Brain Res Bull; 2022 Nov; 190():204-217. PubMed ID: 36244581
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Histochemical accumulation of oxidative damage products is associated with Alzheimer-like pathology in the canine.
    Rofina JE; Singh K; Skoumalova-Vesela A; van Ederen AM; van Asten AJ; Wilhelm J; Gruys E
    Amyloid; 2004 Jun; 11(2):90-100. PubMed ID: 15478464
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease.
    Armstrong RA
    Folia Neuropathol; 2009; 47(4):289-99. PubMed ID: 20054780
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Invited Review - Understanding cause and effect in Alzheimer's pathophysiology: Implications for clinical trials.
    Boche D; Nicoll JAR
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):623-640. PubMed ID: 32643143
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.
    Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK
    Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease.
    Cabezas-Opazo FA; Vergara-Pulgar K; Pérez MJ; Jara C; Osorio-Fuentealba C; Quintanilla RA
    Oxid Med Cell Longev; 2015; 2015():509654. PubMed ID: 26221414
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease.
    Kalra J; Khan A
    Eur J Pharmacol; 2015 Oct; 764():571-581. PubMed ID: 26209363
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Different Populations of Human Locus Ceruleus Neurons Contain Heavy Metals or Hyperphosphorylated Tau: Implications for Amyloid-β and Tau Pathology in Alzheimer's Disease.
    Pamphlett R; Kum Jew S
    J Alzheimers Dis; 2015; 45(2):437-47. PubMed ID: 25547633
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Aging, cortical injury and Alzheimer's disease-like pathology in the guinea pig brain.
    Bates K; Vink R; Martins R; Harvey A
    Neurobiol Aging; 2014 Jun; 35(6):1345-51. PubMed ID: 24360504
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tau Proteins and Tauopathies in Alzheimer's Disease.
    Chong FP; Ng KY; Koh RY; Chye SM
    Cell Mol Neurobiol; 2018 Jul; 38(5):965-980. PubMed ID: 29299792
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The complexity of tau in Alzheimer's disease.
    Naseri NN; Wang H; Guo J; Sharma M; Luo W
    Neurosci Lett; 2019 Jul; 705():183-194. PubMed ID: 31028844
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Do astrocytes collaborate with neurons in spreading the "infectious" aβ and Tau drivers of Alzheimer's disease?
    Dal Prà I; Chiarini A; Gui L; Chakravarthy B; Pacchiana R; Gardenal E; Whitfield JF; Armato U
    Neuroscientist; 2015 Feb; 21(1):9-29. PubMed ID: 24740577
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology.
    Yarchoan M; James BD; Shah RC; Arvanitakis Z; Wilson RS; Schneider J; Bennett DA; Arnold SE
    J Alzheimers Dis; 2017; 56(2):699-706. PubMed ID: 28035936
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease.
    Brier MR; Gordon B; Friedrichsen K; McCarthy J; Stern A; Christensen J; Owen C; Aldea P; Su Y; Hassenstab J; Cairns NJ; Holtzman DM; Fagan AM; Morris JC; Benzinger TL; Ances BM
    Sci Transl Med; 2016 May; 8(338):338ra66. PubMed ID: 27169802
    [TBL] [Abstract][Full Text] [Related]  

  • 80. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.